Literature DB >> 8403497

The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells.

M Shingu1, Y Nagai, T Isayama, T Naono, M Nobunaga, Y Nagai.   

Abstract

It has been suggested that IL-1 produces cartilage matrix degradation by metalloproteinases such as collagenase, and that such degradation is regulated by metalloproteinase inhibitors (TIMP). Therefore, the balance between collagenase and TIMP is an important factor for tissue destruction in inflammatory joints. In the present study the effects of cytokines on collagenase and TIMP production in chondrocytes as well as the effects of cytokines on TIMP production in connective tissue cells were studied. IL-1 beta inhibited TIMP production in endothelial cells while enhancing TIMP production in synovial cells and chondrocytes. In addition, tumour necrosis factor-alpha (TNF-alpha) significantly inhibited and IL-6 significantly enhanced TIMP production in endothelial cells, synovial cells and chondrocytes. In the chondrocyte supernatant, collagenase activity/TIMP ratio was significantly elevated by the addition of either IL-1 beta or TNF-alpha to the cells, whereas the ratio was significantly decreased by IL-6. These results suggest that the cytokine effects on TIMP production are different among the different cell types, and that either IL-1 beta or TNF-alpha induce cartilage matrix degradation by disrupting the collagenase/TIMP balance, while, on the other hand, IL-6 protects the tissue through an opposite effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403497      PMCID: PMC1534355          DOI: 10.1111/j.1365-2249.1993.tb05992.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes.

Authors:  T Tawara; M Shingu; M Nobunaga; T Naono
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  Monoclonal antibodies to bovine collagenase inhibitor.

Authors:  S Kodama; J Kishi; K Obata; K Iwata; T Hayakawa
Journal:  Coll Relat Res       Date:  1987-10

3.  The search for Fc receptors on human tissues and human endothelial cells in culture.

Authors:  M Shingu; Y Hashimoto; A R Johnson; E R Hurd
Journal:  Proc Soc Exp Biol Med       Date:  1981-06

4.  Adenylate cyclase of human articular chondrocytes. Responsiveness to prostaglandins and other hormones.

Authors:  J P Houston; M K McGuire; J E Meats; N M Ebsworth; R G Russell; A Crawford; S Mac Neil
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

5.  Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.

Authors:  J M Dayer; B de Rochemonteix; B Burrus; S Demczuk; C A Dinarello
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

6.  Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis.

Authors:  I Kobayashi; M Ziff
Journal:  Arthritis Rheum       Date:  1975 Sep-Oct

7.  Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

Authors:  T Hirano; T Taga; N Nakano; K Yasukawa; S Kashiwamura; K Shimizu; K Nakajima; K H Pyun; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. I. Synovium.

Authors:  G J Cambray; G Murphy; D P Page-Thomas; J J Reynolds
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

9.  Purification of rabbit bone inhibitor of collagenase.

Authors:  T E Cawston; W A Galloway; E Mercer; G Murphy; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

10.  Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: effects of hydrocortisone and indomethacin.

Authors:  M B McGuire; G Murphy; J J Reynolds; R G Russell
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

View more
  39 in total

Review 1.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  Tissue inhibitor of metalloproteinase 1 regulates resistance to infection.

Authors:  Marie Mei Lee; Bong-June Yoon; Keith Osiewicz; Michael Preston; Brian Bundy; Anna M van Heeckeren; Zena Werb; Paul D Soloway
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Tumor necrosis factor alpha-dependent proinflammatory gene induction is inhibited by cyclic tensile strain in articular chondrocytes in vitro.

Authors:  P Long; R Gassner; S Agarwal
Journal:  Arthritis Rheum       Date:  2001-10

4.  CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts.

Authors:  A Wassenaar; T Verschoor; F Kievits; M T Den Hartog; M L Kapsenberg; V Everts; A Snijders
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

5.  Changes in serum levels of metalloproteinases and their inhibitors by treatment of chronic hepatitis C with interferon.

Authors:  M Arai; M Niioka; K Maruyama; N Wada; N Fujimoto; T Nomiyama; S Tanaka; I Okazaki
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

6.  Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific.

Authors:  A J Freemont; V Hampson; R Tilman; P Goupille; Y Taiwo; J A Hoyland
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

Review 7.  Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis.

Authors:  Cindy L H Yang; Terry C T Or; Marco H K Ho; Allan S Y Lau
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

8.  Parasitic infection as a potential therapeutic tool against rheumatoid arthritis.

Authors:  Shadike Apaer; Tuerhongjiang Tuxun; Hai-Zhang Ma; Heng Zhang; Amina Aierken; Abudusalamu Aini; Yu-Peng Li; Ren-Yong Lin; Hao Wen
Journal:  Exp Ther Med       Date:  2016-09-05       Impact factor: 2.447

Review 9.  Genetic polymorphisms associated with intervertebral disc degeneration.

Authors:  Jillian E Mayer; James C Iatridis; Danny Chan; Sheeraz A Qureshi; Omri Gottesman; Andrew C Hecht
Journal:  Spine J       Date:  2013-03       Impact factor: 4.166

10.  Correlation of Paraoxonase Status with Disease Activity Score and Systemic Inflammation in Rheumatoid Arthritic Patients.

Authors:  Usha Dudeja Bindal; Rahul Saxena; Merajul Haque Siddiqui; Dilutpal Sharma
Journal:  J Clin Diagn Res       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.